Who is sponsoring NCT05209451?

NCT05209451 is sponsored by Mayo Clinic.

What condition does NCT05209451 study?

NCT05209451 studies Smoking Cessation.

Is NCT05209451 still recruiting?

NCT05209451 is currently completed. Last updated 20 September 2024.

Last reviewed 2024-09-20 · How we verify

NCT05209451

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Increasing Digital Equity and Access Among Rural Patients (IDEA) Study

Completed NA Last updated 20 September 2024

What this trial tests

NA trial testing Digital, evidence-based behavioral health program for smoking cessation in Smoking Cessation in 90 participants. Completed in 17 February 2023.

Timeline

11 February 2022

Primary endpoint
17 February 2023

17 February 2023

Quick facts

Lead sponsor	Mayo Clinic
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	90
Start date	11 February 2022
Primary completion	17 February 2023
Estimated completion	17 February 2023
Sites	1 location across United States

Drugs / interventions tested

Digital, evidence-based behavioral health program for smoking cessation
Bluetooth enabled iPad
Coaching Support

Conditions studied

Smoking Cessation — all drugs for Smoking Cessation →

Sponsor

Mayo Clinic

Who can join

18 and older, any sex, with Smoking Cessation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research is to learn more about how access to digital resources impacts healthcare and smoking cessation in rural areas of Minnesota, Iowa, and Wisconsin. Aim 1: Conduct a pragmatic randomized clinical trial and use mixed methods to assess the impact of providing access to technology and/or coaching support on participation in and response to a digital, evidence-based behavioral health program for smoking cessation. Aim 2: Assess the feasibility and patient experience of providing electronic remuneration and a loaner device with data plan coverage to access the Internet for remote clinical trials participation.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Digital therapeutics in the clinic.
Phan P, Mitragotri S, Zhao Z. · · 2023 · cited 39× · PMID 37476062 · DOI 10.1002/btm2.10536
Increasing digital equity to promote online smoking cessation program engagement among rural adults: a randomized controlled pilot trial.
Kelpin S, Brockman TA, Decker PA, Young A, et al · · 2024 · cited 4× · PMID 39375517 · DOI 10.1038/s43856-024-00624-6
Aniqsaaq (To Breathe): Study protocol to develop and evaluate an Alaska Native family-based financial incentive intervention for smoking cessation.
Patten CA, Koller KR, King DK, Prochaska JJ, et al · · 2023 · cited 4× · PMID 37091507 · DOI 10.1016/j.conctc.2023.101129
Revisiting ventilator-induced lung injury: from mechanical power to immunometabolic interaction.
Luo Y, Wu Z, Wu J, You Z, et al · · 2026 · PMID 41659871 · DOI 10.3389/fimmu.2026.1754983
Beta-testing the feasibility of a family-based financial incentives smoking cessation intervention with Alaska Native families: Phase 2 of the Aniqsaaq (to breathe) Study.
Tranby BN, Young AM, Roche AI, Lee FR, et al · · 2025 · PMID 40224301 · DOI 10.1016/j.conctc.2025.101472

Verify or expand the search:

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
NCT07224087 — Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients · Phase 1 · recruiting
NCT07331519 — Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer · NA · recruiting
NCT07210567 — Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors · NA · recruiting
NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting

Other Mayo Clinic trials

Trials by the same sponsor.

NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05209451 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
Last refreshed: 20 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05209451.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing